Abstract
Angiogenesis inhibitors such as tyrosine kinase inhibitors (TKIs) are common therapeutics currently used to treat oncologic disease. Surufatinib is a ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
